US and Kenya Seal $2.5bn Health Partnership to Strengthen Fight Against HIV, Malaria and Polio

The United States and Kenya have finalized a US$2.5 billion health partnership designed to reinforce Kenya’s response to HIV, malaria, polio and other major public-health threats. The agreement, announced on Thursday, marks one of the largest health-sector collaborations between the two countries in recent years.

According to details released by both governments, the United States will provide roughly US$1.7 billion over a five-year period, while Kenya will contribute US$850 million. The funding will support expanded access to essential medicines, improved vaccination coverage, workforce training, and the strengthening of health facilities across the country.

U.S. officials described the deal as a shift toward a “government-to-government” model intended to enhance Kenya’s capacity to manage its own public-health systems. The arrangement reduces reliance on traditional donor-run programmes and places more responsibility on Kenyan institutions for service delivery, accountability, and long-term sustainability.

Kenya’s Ministry of Health welcomed the partnership, noting that it comes at a time when global funding cuts have threatened the continuity of HIV treatment programmes, immunization campaigns, and other critical interventions. Officials say the new structure will help protect vulnerable populations and ensure consistent access to care, particularly in hard-to-reach regions.

Health experts, however, caution that successful implementation will depend on Kenya’s ability to manage resources effectively and maintain transparency in procurement and distribution. Concerns persist that reducing the involvement of non-governmental organizations could affect outreach in remote communities where government presence is limited.

Despite these challenges, the partnership is seen as a significant boost for Kenya’s efforts to build a stronger, more resilient health system. With millions depending on antiretroviral therapy, malaria prevention tools, and childhood vaccinations, the agreement is expected to play a crucial role in safeguarding public health over the coming years.

The funds are scheduled to begin disbursement in early 2026, with both governments expected to monitor progress through periodic evaluations and joint oversight mechanisms.